Strategies of Biotechnological Innovation
Theoretical Concepts, Empirical Evidence, Practical Reports
In it’s core, the planned volume draws from a series of lectures by the same name, which were held by BIOGUM in the Winter Semester 2004-5 and also includes further supplementary contributions. The objective of the volume is to present an overview of current theoretical concepts and empirical findings as well as to sketch the foundation for an innovation’s scene in Northern Germany.
- The modernization of the national policy for innovation: symbolical action or effective instrument?
- A Governance for Biotechnological Innovation in International Comparison
- Challenges and Problems of Utilisation Strategies • Efficient Innovation’s Policy and Management Competence in Biotechnology
- Genesis and Development Supporting Regional Innovation’s Networks from Biotechnology / Medical Technique
- The Roll of Social Capital in Processes of Biotechnological Innovation
- Between Subvention und Market: The Fragile Existence of Younger Biotech Companies (preferable example is Hamburg)
- Bay-to-bio
- Norgenta: The Building and Development of Life Science Clusters in Northern Germany
- MediGate: Cross-linking and Commercialisation of Clinical Research Using the Example of UKE
http://www.uni-hamburg.de/fachbereiche-einrichtungen/fg_ta_med/inno_strat_e.html
Duration: 1. March 2005 - 31. October 2005
Project lead: PD Dr. phil. habil. Günter Feuerstein